$SAVA High Variability in Levels of Biomarkers in Control Arm of Phase 2b Study May Drive Reassessment of Overall Study Results + Effects Of PTI-125 on Cognition, Other Analysis and Data Expected 2nd Half 2020 

#daytrading #stocks